Does GLUCARPIDASE Cause Hypervolaemia? 8 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Hypervolaemia have been filed in association with GLUCARPIDASE (Voraxaze). This represents 2.9% of all adverse event reports for GLUCARPIDASE.
8
Reports of Hypervolaemia with GLUCARPIDASE
2.9%
of all GLUCARPIDASE reports
0
Deaths
6
Hospitalizations
How Dangerous Is Hypervolaemia From GLUCARPIDASE?
Of the 8 reports, 6 (75.0%) required hospitalization.
Is Hypervolaemia Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for GLUCARPIDASE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does GLUCARPIDASE Cause?
Off label use (83)
Underdose (61)
Laboratory test interference (57)
Drug effect incomplete (31)
Rebound effect (28)
Drug ineffective (27)
Blood creatinine increased (26)
Acute kidney injury (24)
Toxicity to various agents (24)
Renal failure (20)
What Other Drugs Cause Hypervolaemia?
TREPROSTINIL (580)
CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (428)
AMBRISENTAN (205)
MACITENTAN (202)
FUROSEMIDE (139)
AMLODIPINE (122)
CYCLOPHOSPHAMIDE (118)
SACUBITRIL\VALSARTAN (115)
TACROLIMUS (100)
PREDNISONE (98)
Which GLUCARPIDASE Alternatives Have Lower Hypervolaemia Risk?
GLUCARPIDASE vs GLUCOPHAGE
GLUCARPIDASE vs GLUCOSAMINE
GLUCARPIDASE vs GLUTAMINE
GLUCARPIDASE vs GLUTATHIONE
GLUCARPIDASE vs GLYBURIDE